A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis. Vollmer TL, Sorensen PS, Selmaj K, Zipp F, Havrdova E, Cohen JA, Sasson N, Gilgun-Sherki Y, Arnold DL, On behalf of the BRAVO Study Group J Neurol. 2014 Feb 18. Epub 2014 Feb 18. PMID: 24535134. Abstract CommentRecommendBookmarkWatch